Pharmaeconomics and evaluation of health technologies
Course objectives
Knowledge and understanding: Students will be able to understand the theoretical background of the pharmacoeconomics evaluation techniques, in the fields of Biopharmaceutical Industry, with particular regard to cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis. Applying knowledge and understanding Students will be able to use the modelling frameworks, the budget impact analysis and the patient reported outcomes through examples taken from national and international literature and the help of case studies, with a specific focus on data sources and accounting for uncertainty. Making judgement Students will develop an autonomous judgment capability on a theoretical and practical perspective related to pharmacoeconomics and outcome research. Communication skills Students will develop an attitude for pharmacoeconomic reasoning and the capacity for argumentation on the economic evaluation of biopharmaceutical innovation. Learning skills Students will be able to deal with other subjects of the health economics field thanks to the principles and practice of pharmacoeconomics and of outcome research
Channel 1
SILVIA CORETTI
Lecturers' profile
Program - Frequency - Exams
Course program
1. Peculiarities of the pharmaceutical markets
1.1. The market stricture
1.2. R&D
1.3. The price of drugs
1.4. Peculiarities of public health care systems
2. The regulatory process of drugs
2.1. The European Rules
2.2. The American Rules
3. Basic Types of economic evaluations
3.1. Why is economic evaluation important?
3.2. Economic evaluation techniques
3.3. The relevant cost and outcome categories in economic evaluations
4. Critical assessment of an economic evaluation
4.1. Elements of a good economic evaluation
4.2. Focus on the generalizability of results
4.3. Lab 1: critical assessment of a published article
5. Cost analysis:
5.1. Basics
5.2. Differential timing of costs
5.3. Allocation of general costs
5.4. Allocation of productivity costs
6. Cost-effectiveness analysis
6.1. General features
6.2. Interpreting a cost-effectiveness ratio
6.3. From incremental cost effectiveness ratio to net benefit
7. Cost-utility analysis
7.1. General features
7.2. Utilities
7.3. Elicitation methods (with practical exercises)
7.4. Threshold values
8. Basics of decision modelling:
8.1. Simple decision three
8.2. Markov model
8.3. Budget impact analysis
8.4. Labs 2-4: A full assessment
8.5. Basics of uncertainty analysis in decision modelling
Prerequisites
There are no specific requirements.
Books
Main book: Drummond, M., Sculpher, M.J., Torrance, G.W., O’Brien, B.J., Stoddart, J.L. (2005). Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
Additional readings:
• Selected Chapters of: Briggs, A., Sculpher, M., & Claxton, K. (2006). Decision modelling for health economic evaluation. Oup Oxford.
• Selected scientific papers.
Frequency
Attendance is not mandatory but strongly recommended.
Exam mode
The course will not include intermediate exams. However, the outputs of the two labs, to which students can participate on voluntary basis, will provide additional bonuses that contribute to the final mark.
The final exam is written. It includes a multiple choice test and 2 open-ended questions.
Lesson mode
The course will be made up of traditional lectures and labs to be managed individually by students or in small groups.
SILVIA CORETTI
Lecturers' profile
Program - Frequency - Exams
Course program
1. Peculiarities of the pharmaceutical markets
1.1. The market stricture
1.2. R&D
1.3. The price of drugs
1.4. Peculiarities of public health care systems
2. The regulatory process of drugs
2.1. The European Rules
2.2. The American Rules
3. Basic Types of economic evaluations
3.1. Why is economic evaluation important?
3.2. Economic evaluation techniques
3.3. The relevant cost and outcome categories in economic evaluations
4. Critical assessment of an economic evaluation
4.1. Elements of a good economic evaluation
4.2. Focus on the generalizability of results
4.3. Lab 1: critical assessment of a published article
5. Cost analysis:
5.1. Basics
5.2. Differential timing of costs
5.3. Allocation of general costs
5.4. Allocation of productivity costs
6. Cost-effectiveness analysis
6.1. General features
6.2. Interpreting a cost-effectiveness ratio
6.3. From incremental cost effectiveness ratio to net benefit
7. Cost-utility analysis
7.1. General features
7.2. Utilities
7.3. Elicitation methods (with practical exercises)
7.4. Threshold values
8. Basics of decision modelling:
8.1. Simple decision three
8.2. Markov model
8.3. Budget impact analysis
8.4. Labs 2-4: A full assessment
8.5. Basics of uncertainty analysis in decision modelling
Prerequisites
There are no specific requirements.
Books
Main book: Drummond, M., Sculpher, M.J., Torrance, G.W., O’Brien, B.J., Stoddart, J.L. (2005). Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
Additional readings:
• Selected Chapters of: Briggs, A., Sculpher, M., & Claxton, K. (2006). Decision modelling for health economic evaluation. Oup Oxford.
• Selected scientific papers.
Frequency
Attendance is not mandatory but strongly recommended.
Exam mode
The course will not include intermediate exams. However, the outputs of the two labs, to which students can participate on voluntary basis, will provide additional bonuses that contribute to the final mark.
The final exam is written. It includes a multiple choice test and 2 open-ended questions.
Lesson mode
The course will be made up of traditional lectures and labs to be managed individually by students or in small groups.
- Lesson code10616883
- Academic year2024/2025
- CourseHealth Economics
- CurriculumSingle curriculum
- Year1st year
- Semester2nd semester
- SSDSECS-P/03
- CFU9
- Subject areaEconomico